MEDVi vs Sequence: Prices, Programs & Reviews (2026)
Side-by-side comparison updated for 2026. ClearScores, pricing, medications, and ratings compared.
Quick Verdict
MEDVi has the higher ClearScore (83 vs 79)
Sequence is more affordable ($99/mo vs $199/mo)
MEDVi has higher ratings (4.5/5 vs 4.3/5)
Sequence scores better on value (4.4/5 vs 4.1/5)
MEDVi
$199/mo
starting price
The tirzepatide specialist. Compounded Mounjaro/Zepbound molecule with body composition tracking and clinical monitoring.
Sequence
$99/mo
starting price
Specializes in getting brand-name GLP-1s covered by insurance. They handle prior authorization so you don't have to.
MEDVi vs Sequence: Full Comparison
| MEDVi | Sequence | |
|---|---|---|
| ClearScore | 83/100 ✓ | 79/100 |
| Overall Rating | 4.5/5 ✓ | 4.3/5 |
| Review Count | 112 ✓ | 96 |
| Starting Price | $199/mo | $99/mo ✓ |
| Medications | Compounded Tirzepatide, Compounded Semaglutide | Branded Wegovy, Branded Zepbound, Branded Mounjaro, Branded Ozempic ✓ |
| Telehealth | Yes | Yes |
| Insurance | Not accepted | Accepted |
| HSA/FSA | Accepted | Accepted |
| Founded | 2021 | 2021 |
| States Served | All 50 states | All 50 states |
Programs & Pricing
MEDVi Programs
Tirzepatide Program
$249/mo
Medications: Compounded Tirzepatide
- Medication
- Body Composition Tracking
- Clinical Monitoring
- Free Shipping
Semaglutide Program
$199/mo
Medications: Compounded Semaglutide
- Medication
- Clinical Monitoring
- Free Shipping
Sequence Programs
Insurance-Covered GLP-1
$99/mo + insurance copay
Medications: Branded Wegovy, Branded Zepbound, Branded Mounjaro, Branded Ozempic
- Insurance Navigation
- Prior Authorization
- Clinician Support
- Prescription Management
Ratings Breakdown
| Category | MEDVi | Sequence |
|---|---|---|
| Overall | | |
| Value | | |
| Ease of Use | | |
| Support | | |
| Medication Quality | | |
| Results | | |
The Bottom Line
MEDVi edges out Sequence with a ClearScore of 83 vs 79. Sequence is more affordable starting at $99/mo compared to $199/mo. For customer support, MEDVi rates higher (4.6/5). The best choice depends on your priorities, medication preferences, and budget.